Skip to main content
Top
Published in: Head & Neck Oncology 1/2012

Open Access 01-12-2012 | Research

Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study

Authors: Gabriel Pereira, Joaquim Castro Silva, Eurico Monteiro

Published in: Head & Neck Oncology | Issue 1/2012

Login to get access

Abstract

Background

The management of cervical lymph node metastases from an unknown primary tumor remains a controversial subject. Recently, Positron Emission Tomography (PET) has proved useful in the detection of these tumors, even after an unsuccessful conventional diagnostic workup. This study was performed to assess the role of PET in the detection of occult primary head and neck carcinomas.

Methods

A retrospective analysis of a four year period at a tertiary referral oncology hospital was conducted.

Results

Of the 49 patients with cervical metastases of carcinoma from an unknown primary, PET detected a primary in 9 patients and gave 5 false positive and 4 false negative results. Detection rate, sensitivity, specificity and accuracy were of 18.4%, 69.2%, 86.1% and 81.6%, respectively. PET was also of substantial benefit in detecting distant metastatic disease and, thus, altered therapeutic strategies in a significant amount of patients.

Conclusions

Therefore, PET is a valuable tool in the management of patients with occult primary head and neck carcinoma, not only because it provides additional information as to the location of primary tumors, but also due to the fact that it can detect unexpected distant metastases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rusthoven KE, Koshy M, Paulino AC: The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004, 101: 2641-2649. 10.1002/cncr.20687.CrossRefPubMed Rusthoven KE, Koshy M, Paulino AC: The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004, 101: 2641-2649. 10.1002/cncr.20687.CrossRefPubMed
2.
go back to reference Mahoney EJ, Spiegel JH: Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor. Otolaryngol Clin N Am. 2005, 38: 87-97. 10.1016/j.otc.2004.10.014.CrossRef Mahoney EJ, Spiegel JH: Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor. Otolaryngol Clin N Am. 2005, 38: 87-97. 10.1016/j.otc.2004.10.014.CrossRef
3.
go back to reference Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, Westhofen M: Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 2000, 126: 1457-1461. 10.1001/archotol.126.12.1457.CrossRefPubMed Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, Westhofen M: Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 2000, 126: 1457-1461. 10.1001/archotol.126.12.1457.CrossRefPubMed
4.
go back to reference Greven KM, Williams DW, McGuirt WF, Harkness BA, D’Agostino RB, Keyes JW, Watson NE: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001, 23: 942-946. 10.1002/hed.1136.CrossRefPubMed Greven KM, Williams DW, McGuirt WF, Harkness BA, D’Agostino RB, Keyes JW, Watson NE: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001, 23: 942-946. 10.1002/hed.1136.CrossRefPubMed
5.
go back to reference Jungehulsing M, Scheidhauer K, Damm H, Pietrzyk U, Eckel H, Schicha H, Stennert E: 2[F]-Fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000, 123: 294-301. 10.1067/mhn.2000.104807.CrossRefPubMed Jungehulsing M, Scheidhauer K, Damm H, Pietrzyk U, Eckel H, Schicha H, Stennert E: 2[F]-Fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000, 123: 294-301. 10.1067/mhn.2000.104807.CrossRefPubMed
6.
go back to reference Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ: 18 F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer. 1999, 86: 2370-2377. 10.1002/(SICI)1097-0142(19991201)86:11<2370::AID-CNCR27>3.0.CO;2-B.CrossRefPubMed Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ: 18 F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer. 1999, 86: 2370-2377. 10.1002/(SICI)1097-0142(19991201)86:11<2370::AID-CNCR27>3.0.CO;2-B.CrossRefPubMed
8.
go back to reference Aassar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, Dillon WP, Hawkins RA: Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999, 210: 177-181. 10.1148/radiology.210.1.r99ja48177.CrossRefPubMed Aassar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, Dillon WP, Hawkins RA: Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999, 210: 177-181. 10.1148/radiology.210.1.r99ja48177.CrossRefPubMed
9.
go back to reference Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenbburg JL, Vaalburg W, Vermey A: Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998, 82: 1160-1166. 10.1002/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3.CrossRefPubMed Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenbburg JL, Vaalburg W, Vermey A: Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998, 82: 1160-1166. 10.1002/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3.CrossRefPubMed
10.
go back to reference Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004, 231: 65-72. 10.1148/radiol.2311030271.CrossRefPubMed Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004, 231: 65-72. 10.1148/radiol.2311030271.CrossRefPubMed
11.
go back to reference Greven KM, Keyes JW, Williams DW, McGuirt WF, Joyce WT: Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer. 1999, 86: 114-118. 10.1002/(SICI)1097-0142(19990701)86:1<114::AID-CNCR16>3.0.CO;2-E.CrossRefPubMed Greven KM, Keyes JW, Williams DW, McGuirt WF, Joyce WT: Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer. 1999, 86: 114-118. 10.1002/(SICI)1097-0142(19990701)86:1<114::AID-CNCR16>3.0.CO;2-E.CrossRefPubMed
12.
go back to reference Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA: Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005, 131: 626-629. 10.1001/archotol.131.7.626.CrossRefPubMed Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA: Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005, 131: 626-629. 10.1001/archotol.131.7.626.CrossRefPubMed
13.
go back to reference Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998, 20: 739-744. 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0.CrossRefPubMed Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998, 20: 739-744. 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0.CrossRefPubMed
14.
go back to reference Koch WM, Bhatti N, Williams MF, Eisele DW: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001, 124: 331-333. 10.1067/mhn.2001.114309.CrossRefPubMed Koch WM, Bhatti N, Williams MF, Eisele DW: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001, 124: 331-333. 10.1067/mhn.2001.114309.CrossRefPubMed
15.
go back to reference McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM: Occult tonsillar carcinoma in the unknown primary. Laryngoscope. 1998, 108: 1605-1610. 10.1097/00005537-199811000-00004.CrossRefPubMed McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM: Occult tonsillar carcinoma in the unknown primary. Laryngoscope. 1998, 108: 1605-1610. 10.1097/00005537-199811000-00004.CrossRefPubMed
16.
go back to reference Chepeha D, Koch W, Pitman K: Management of unknown primary tumor. Head Neck. 2003, 6: 499-504.CrossRef Chepeha D, Koch W, Pitman K: Management of unknown primary tumor. Head Neck. 2003, 6: 499-504.CrossRef
17.
go back to reference Fogarty GB, Peters LJ, Stewart J, Scott C, Rischin D, Hicks RJ: The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003, 25: 138-145. 10.1002/hed.10191.CrossRefPubMed Fogarty GB, Peters LJ, Stewart J, Scott C, Rischin D, Hicks RJ: The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003, 25: 138-145. 10.1002/hed.10191.CrossRefPubMed
Metadata
Title
Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study
Authors
Gabriel Pereira
Joaquim Castro Silva
Eurico Monteiro
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2012
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-4-34

Other articles of this Issue 1/2012

Head & Neck Oncology 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine